John Apathy Joins DataJoint as Strategic Advisor
DataJoint, a number one informatics platform revolutionizing information administration and evaluation in scientific analysis and the life sciences sector, right now introduced the appointment of John Apathy as a Strategic Advisor, deepening the corporate’s experience in data-driven transformation throughout key analysis and growth domains.
John Apathy brings greater than 35 years of expertise in consulting and know-how management within the biopharmaceutical business, centered on enabling world-class analysis and growth via superior information and digital approaches. His appointment underscores DataJoint’s dedication to accelerating productiveness and scientific discovery via computational information integration, reproducibility, and AI-powered analytics.
In his present position as Chief Solutions Officer at XponentL Data, a Genpact firm, Apathy advises purchasers on maximizing enterprise worth from information and AI. His in depth background in modernizing information architectures and deploying platforms that remodel uncooked information into strategic property has guided main firms in harnessing the total potential of digital innovation in science. Previously, Apathy served as the worldwide Head of Digital/IT for Research and Early Development at Bristol Myers Squibb, the place he led initiatives uniting high-performance computing, translational informatics, and AI to drive discovery and precision drugs. His profession additionally consists of management roles at Celgene, GlaxoSmithKline, Wyeth, Accenture, PA Consulting Group, and Eli Lilly and Company.
“Digital transformation is accelerating via the appliance of AI know-how in life sciences analysis and growth, and new information and analytical capabilities such as DataJoint are important to advancing our understanding of complicated human biology,” stated John Apathy. “DataJoint’s SciOps platform seamlessly integrates devices, information, code, and computation into automated, clear, and AI-ready workflows. I’m excited to contribute my expertise to assist drive DataJoint’s mission to enhance the productiveness and influence of analysis.”
“John’s deep expertise main digital and information transformation initiatives in biopharma R&D makes him an impressive addition to our advisory crew,” stated Jim Olson, CEO of DataJoint. “His perception and steerage will assist us speed up our progress and increase our influence throughout the life sciences, the place information integration and computational reproducibility are extra crucial than ever.”
Used by greater than 100 analysis labs at establishments together with Johns Hopkins, Harvard, UCSF, and UCL, DataJoint’s platform addresses the challenges of fragmented information administration and irreproducible analysis workflows. With leaders like Apathy becoming a member of its mission, DataJoint continues to redefine scientific information administration and AI-ready analysis, fostering collaboration and discovery throughout academia and business.
The publish John Apathy Joins DataJoint as Strategic Advisor first appeared on AI-Tech Park.
